Compugen Ltd.

NASDAQ:CGEN

Biotechnology

Healthcare
$1.96 +0.50%

+$0.01 today

Market cap
$185.66M
Beta
2.74
P/E (TTM)
5.4
EPS (TTM)
$0.37
52W Low $1.30High $3.24

Volume 0.15M

Average 0.48M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

$31.63M

FY 2025 · Annual

-36.2% YoY

Investing Cash Flow

$30.00M

FY 2025 · Annual

Financing Cash Flow

$10.60M

FY 2025 · Annual

+1814.1% YoY

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(34.2M)(33.69M)(18.75M)(14.23M)35.34M
Depreciation & Amortization461K482K476K486K475K
Deferred Income Tax00000
Stock-Based Compensation4.28M4.33M3.55M3.02M0
Change in Working Capital6.82M(5.55M)(20.71M)62.05M(5.35M)
Accounts Receivables2M3.04M(61.11M)59.93M360K
Inventory(3.37M)0000
Accounts Payables3.37M(1.6M)3.51M(4.41M)517K
Other Working Capital3.79M(7M)36.9M6.53M(6.23M)
Other Non-Cash Items(573K)515K(452K)(1.72M)1.16M
Operating Cash Flow(22.75M)(34.51M)(35.89M)49.6M31.63M
Capital Expenditures(292K)(487K)(172K)(118K)(306K)
Acquisitions (Net)3K2K001K
Purchases of Investments(129.95M)(76.9M)(53.71M)(159.75M)(96.07M)
Sales of Investments136.85M114.45M89.39M113.95M126.37M
Other Investing Activities000(329K)0
Investing Cash Flow6.62M37.06M35.51M(46.25M)30M
Debt Repayment00000
Common Stock Issued14.96M353K3.08M544K10.61M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities1.88M0010K(4K)
Financing Cash Flow16.84M353K3.08M554K10.6M
Effect of Forex Changes469K(584K)129K68K135K
Net Change in Cash704K2.91M2.83M3.97M72.37M
Free Cash Flow(23.04M)(34.99M)(36.06M)49.49M31.33M

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income$35.3M
+ D&A$475.0K
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$5.3M
+ Other Non-Cash$1.2M
= Operating Cash Flow$31.6M
- Capex-$306.0K
= Free Cash Flow$31.3M

Analysis

FY2025 free cash flow is $31.3M. FCF conversion is 88.6% of net income. Operating cash flow was $31.6M, with capex of -$306.0K. The largest bridge item is Working Capital at -$5.3M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 9, 2026
6-K6-K filingSep 10, 2026
6-K6-K filingAug 3, 2026
6-K6-K filingAug 3, 2026
4Statement of changes in beneficial ownershipJul 30, 2026

Does CGEN generate free cash flow?

Compugen Ltd. (CGEN) generated $31.33M of free cash flow in fiscal 2025.

How much operating cash flow does CGEN produce?

Operating cash flow was $31.63M, before capital expenditures of $306,000.00.